Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions.

Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions.
复制标题

糖尿病性黄斑水肿,视网膜病变和与年龄相关的黄斑变性为炎症状况。

DOI:
10.5114/aoms.2016.61918
复制
发表时间:
2016-10-01
期刊:
Archives of medical science : AMS
影响因子:
--
通讯作者:
Das UN
Das UN
中科院分区:
其他
文献类型:
--
作者:
Das UN

文献摘要

参考文献

被引文献

相似文献

糖尿病黄斑水肿 (DME) 和糖尿病视网膜病变 (DR) 是影响约 25% 长期 1 型和 2 型糖尿病患者的并发症,是视力和生活质量显着下降的主要原因。年龄相关性黄斑变性 (AMD) 并不罕见,糖尿病通过改变血流动力学、增加氧化应激、积累晚期糖基化终产物等影响 AMD 的发病和进展。最近的研究表明,DME、DR 和 AMD 是一种炎症性疾病,其特征是血-视网膜屏障破坏、炎症过程和血管通透性增加。在 DME、DR 和 AMD 中起主导作用的关键因素似乎是血管紧张素 II、前列腺素和血管内皮生长因子以及抗炎生物活性脂质的缺乏。促炎和抗炎类二十烷酸之间的不平衡以及促血管生成因子的产生增加可能引发 DME、DR 和 AMD 的发病和进展。这意味着具有抗炎作用并抑制血管生成因子产生的生物活性脂质可用于预防和治疗 DME、DR 和 AMD。
Diabetic macular edema (DME) and diabetic retinopathy (DR) are complications affecting about 25% of all patients with long-standing type 1 and type 2 diabetes mellitus and are a major cause of significant decrease in vision and quality of life. Age-related macular degeneration (AMD) is not uncommon, and diabetes mellitus affects the incidence and progression of AMD through altering hemodynamics, increasing oxidative stress, accumulating advanced glycation end products, etc. Recent studies suggest that DME, DR and AMD are inflammatory conditions characterized by a breakdown of the blood-retinal barrier, inflammatory processes and an increase in vascular permeability. Key factors that seem to have a dominant role in DME, DR and AMD are angiotensin II, prostaglandins and the vascular endothelial growth factor and a deficiency of anti-inflammatory bioactive lipids. The imbalance between pro- and anti-inflammatory eicosanoids and enhanced production of pro-angiogenic factors may initiate the onset and progression of DME, DR and AMD. This implies that bioactive lipids that possess anti-inflammatory actions and suppress the production of angiogenic factors could be employed in the prevention and management of DME, DR and AMD.
DOI: 10.1158/1535-7163.mct-10-0173
发表时间: 2010-08-01
影响因子: 5.7
作者:
Chen, Ying;Hao, Hua;Chen, Xiaoping
通讯作者: Chen, Xiaoping
DOI: 10.1007/s10753-012-9567-x
发表时间: 2013-04-01
期刊: INFLAMMATION
影响因子: 5.1
作者:
Chen, Zhiqiao;Wu, Zhe;Li, Siying
通讯作者: Li, Siying
DOI: 10.1096/fj.06-7918com
发表时间: 2007-07-01
期刊: FASEB JOURNAL
影响因子: 4.8
作者:
Biteman, Benjamin;Hassan, Iram R.;Gronert, Karsten
通讯作者: Gronert, Karsten
DOI: 10.1002/art.1780380609
发表时间: 1995-06-01
影响因子: --
作者:
BRATT, J;GYLLENHAMMAR, H
通讯作者: GYLLENHAMMAR, H
DOI: 10.1038/nm1095-1024
发表时间: 1995-10-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
ALON, T;HEMO, I;KESHET, E
通讯作者: KESHET, E